(Q73015227)
Statements
Gemtuzumab ozogamicin in pediatric CD33-positive acute lymphoblastic leukemia: first clinical experiences and relation with cellular sensitivity to single agent calicheamicin (English)
C M Zwaan
D Reinhardt
H Jürgens
D R Huismans
K Hählen
O P Smith
A Biondi
E R van Wering
J Feingold
G J L Kaspers
1 February 2003